Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Bilberry Extract Tablets 7500 mg Tablet is a Health Canada–registered human drug (DIN 02241237) held by Abundance Naturally Ltd, containing Vaccinium Myrtillus. Health Canada lists its status as Cancelled Pre Market (status date 20 Jun 2017). Nexara Health has matched 4 registrations of Vaccinium Myrtillus across 1 other regulated market.

Health Canada registration

DIN02241237
Brand nameBilberry Extract Tablets
Active ingredientVaccinium Myrtillus
Strength7500 mg
Dosage formTablet
RouteOral
CompanyAbundance Naturally Ltd
StatusCancelled Pre Market — 20 Jun 2017
ClassHuman
ATC
AHFS92:01.00* ; See footnote
Regulator recordHealth Canada DPD entry · Product monograph

Vaccinium Myrtillus registered in other markets

4 registrations of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
MalaysiaAfdhal Bilberry 450mg CapsulesMinda Tulus EnterpriseNatural ProductPRODUCT APPROVEDNPRA
MalaysiaGold Mountain Pd CapsuleGold Mountain Global Sdn. Bhd.Natural ProductPRODUCT APPROVEDNPRA
MalaysiaOne Vision Plus Bilberry Extract 350mg CapsuleIntan Biotech Industries Sdn BhdNatural ProductPRODUCT APPROVEDNPRA
MalaysiaTHP Ocuberry CapsuleZas Pharma Sdn BhdNatural ProductPRODUCT APPROVEDNPRA

See every manufacturer of Vaccinium Myrtillus worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Bilberry Extract Tablets (DIN 02241237) marketed in Canada?

No. Health Canada lists DIN 02241237 as Cancelled Pre Market as of 20 Jun 2017.

Who holds the Canadian licence for this product?

Abundance Naturally Ltd is the company of record in the Health Canada Drug Product Database.

Is Vaccinium Myrtillus registered outside Canada?

Yes — Nexara Health has matched 4 registrations in 1 other market (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02241237, status date 2017-06-20; national medicine registries: NPRA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02241237, status date 2017-06-20; national medicine registries: NPRA.

Health Canada Drug Product Database (DPD), DIN 02241237, status date 2017-06-20; national medicine registries: NPRA. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.